Application of IgM-capture ELISA on Myanmar Dengue Patients\u27 Serum Samples Collected in 1994 by Kyaw-Zi n-Thant et al.
T rop. Med., 38 (1), 1-6, March, 1996
Application of IgM-capture ELISA on MyanmarDengue
Patients' Serum Samples Collected in 1994
Kyaw-Zin-Thant1'2, Khin-Mar-Aye1'2 , Soe-Thein2,
Than-Swe2 and Akira IGARASHI1
^Department of Virology, Institute of Tropical Medicine, Nagasaki University,
1 - 12-4 Sakamoto, Nagasaki 852, Japan
2Virology Research Division, Department of Medical Research, Ministry of
Health, Yangon, Union of Myanmar
Abstract: Seventy serum samples from clinically diagnosed dengue patients admitted to
the North Okkalapa General Hospital, Yangon, Union of Myanmar, in 1994, were used to
obtain the confirmed virological diagnosis by IgM-capture ELISA using all four types of
dengue antigens raised by cell culture method. Sixty-two out of 70 specimens (88.6%)
showed positive IgM ELISA titer against one or more assay antigen. Single application of
dengue 2 antigen could detect 59 out of 62 positive sera (95.1% of total positives), whereas
three more samples could be detected by using other serotypic antigens (either single anti-
gen or double antigens in combination). Ten samples showing positive by single dengue
antigen but negative results by the rest could possibly be due to the primary infection which
showed serotype specific immuneresponse.
Key words: Dengue virus infection, IgM-capture ELISA, Myanmar
1
INTRODU CTI ON
The enzyme-linked immunosorbent assay (ELISA) has first been introduced to the
field of medical science in the 1970's (Engvall and Perlmann, 1971). Since the ELISA
methods can be used to assay both antibodies and antigens, the wide applicability of these
techniques are evident nowadays especially in the fields of infectious diseases (Sever and
Madden, 1977; Voller and Ceska, 1978). The first use of ELISA for the measurement of viral
antibodies was done by Voller and Bidwell (1975) on rubella virus. IgM-capture ELISA was
proved to be an efficient diagnostic tool for the rapid diagnosis of dengue infections, due to
its rapidity, simplicity, reproducibility, acceptable running cost and diagnostic capability even
with a single serum specimen. Because of these characteristic features, it has been success-
fully used as a supplement and/or substitute to the pre-existing classical serological tests,
namely complement-fixation (CF), hemagglutination-inhibition (HI) and neutralization (N)
tests. Many researchers have utilized this technique for the last two decades (Burke, 1983;
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Bundo and Igarashi, 1985; Lam et al, 1987; Innis et al, 1989; Cardosa and Zuraini, 1991;
Cardosa et al., 1992). We do also apply the IgM-capture ELISA technique in this study on
Myanmardengue patients' serum samples using all four dengue serotypic antigens derived
from cell culture methods, in order to confirm its diagnostic capability.
MATERIALS AND METHODS
Samples
Seventy serum samples from the patients clinically diagnosed as dengue virus infection,
and admitted to the North Okkalapa General Hospital, Yangon, Union of Myanmar, in the
period of June and July, 1994, were used in this study. The clinical diagnosis was made ac-
cording to the WHO criteria (WHO, 1986).
Assay antigens production
Three Roux bottles of Aedes albopidus, clone C6/36 cells (Igarashi, 1978), and one Roux
bottle of vero cells were grown in 40 ml/Roux bottle of Eagle's medium in Earle's saline
supplemented with 0.2 mMeach nonessential amino acids and 9% heat-inactivated fetal calf
serum, at 28°C for C6/36 cells and at 37°C for vero cells. When 80% monolayers were ob-
tained, growth media were removed from the cell cultures and 1.5 ml each of seed viruses
{prototypes: Hawaiian strain for dengue type 1 virus (Dl), New Guinea B strain for dengue
type 2 virus (D2), H-87 strain for dengue type 3 virus (D3) and H-241 strain for dengue
type 4 virus (D4)} were inoculated. Adsorpiton was carried out for 2 hours at 28°C and 37°C
for C6/36 cells and vero cells, respectively, and spreading the inoculum over cell sheet every
30 minutes. After adsorption, 40 ml of maintenance medium (the same growth medium in
which serum concentration was reduced to 2%) was poured into each culture bottle. Then Dl
culture bottle was incubated at 32°C for 5 days, D2 culture bottle at 37°C for 5 days, D3
culture bottle at 28°C for 7 days, and D4 culture bottle at 37°C for 7 days. After the Infected
culture fluid of Dl, D2, D3 and D4 viruses were harvested accordingly, the antigen detection
ELISA was performed by micro sandwich method of Voller et al (1976). The antigen ELISA
titers of the harvested culture fluid were estimated by comparing their ELISA-OD with
those of serially diluted standard positive specimens with predetermined endpoint titer
(Igarashi et al, 1981; Morita et al, 1982). The titers of harvested culture fluid were found to
be 16, 64, 3 and 4 ELISA units for 1)1, D2, D3 and D4 viruses, respectively. These culture
fluids were stored at 4°C until using as assay antigens for the further experiments.
IgM- capture ELISA
IgM-capture ELISA was performed as described previously (Bundo and Igarashi,
1985). Incubation at room temperature for 1 hour and reagent volume of 100^1/well for each
reaction step were applied unless otherwise specified. The 96-well flat bottom microplates
(Nuhc, Denmark) were coated with anti-human IgM (//-chain specific) goat IgG (Cappel
3
PA, USA) diluted 1: 200 with 0.05M carbonate-bicarbonate buffer, pH 9.6, containing
0.01% NaN3, and incubated at 4°C overnight. The plates were inactivated by Block Ace
(Yukijirushi, Japan), followed by washing with PBS-Tween (0.05% Tween 20 and 0.01%
NaN3 in PBS) four times without incubation, using a ICN Titertek microplate washer (Flow,
USA). Test sera, known dengue IgM positive and negative1 control sera were diluted 1: 100
with PBS-Tween, and added to duplicate wells according to the set up protocol. The plates
were washed as above. Dl, D2, D3 and D4 antigens were added to the duplicate wells. After
washing as above, the plates were reacted with horseradish peroxidase (HRPO)-conjugated
antiflavivirus IgG at 1:100 dilution in PBS-Tween. This reagent was prepared by conjugat-
ing the antiflavivirus IgG with HRPO (Sigma, type ¥, USA), using Wilson and Nakane's
method (1978). After washing as above, color reaction was carried out by the addition of
substrate solution of 0.5mg/ml o-phenylenediamine dihydrochloride (OPD) and 0.02% H202
in 0.05M citrate phosphate buffer, pH 5. After 1 hour incubation in the dark at room tem-
perature, the reaction was stopped by adding 100^1 of IN sulphuric acid to each well. The
OD492 on each well was recorded by an ELISA reader using 620nm as a reference
wavelength. The samples were determined as positive when their ELISA-OD is twice or
more than that of the cut-off value calculated from the average reading of the negative
control sera (P/N ratio>2.0).
RESULTS AND DISCUSSION
Positive case detective capability of four different types of dengue antigens by Ig-
M-capture ELISA on Myanmar dengue patients' serum samples was shown in Table 1. Out
Table 1. Dengue positive case detection by IgM-ELISA on Myanmardengue
patients' serum samples using different assay antigens
A ssay antigens Samples showing
7o to totaltest sera
Dl D2 D3 D4 response (70)
29 29/70(41. 4%)
+ + + 13 14/70( 20%)



















(Source of the samples: North Okkalapa General Hospital, Yangon, Union of
Myanmar, in 1994)
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of 70 serum samples tested, 62 samples (88.6%) showed positive IgM-ELISA titer against
one or moreassay antigen. Twenty-nine samples (41.4%) showed positive with all four assay
antigens, whereas 14 samples (20%) and 9 samples (12.9%) were positive with triple and
double antigens, respectively. There is no single specimen which was positive by either Dl or
D4 antigen, but negative by other triple antigens. There are 9 specimens which were positive
by D2 antigen but negative by other antigens, while single specimen showed positive by D3
antigen with negative results of the rest. Eight samples (ll.4%) showed negative by all four
types of assay antigens.
Even using only D2 antigen could detect 59 out of 62 positive sera (i. e. 95.1% of total
positives) (Table 2). This is a reasonably high sensitivity rate which is essential for routine
diagnostic assays. By using other serotypic antigens (either single antigen or double antigens
in combination), three more serum samples could be detected. This additive role of serotypic
antigens other than D2 antigen is an interesting outcome of this study. Nine samples showing
positive by single D2 antigen, and one sample showing positive by single D3 antigen (Table
1) could possibly be due to the primary infection which showed serotype specific immune
response.
Table 2 shows that 64 ELISA unit D2 antigen could detect 95.1% of total positive sera,
whereas 16 unit Dl antigen, 3 unit D3 antigen and 4 unit D4 antigen could detect 77.4%,
75.8% and 51.6% of total positive sera, respectively. It might be due to the fact that high
titered dengue antigen could detect the higher number of serum samples than the low titered
antigens do. On the other hand, it might possibly reflect the distribution pattern or the
prevalence of dengue serotypes in Yangon community in 1994.
Since IgM-capture ELISA method has been used to detect dengue virus infection in
Myanmarpatients' serum samples (May La Linn et al, 1985; Khin-Mar-Aye et al, 1995),
and to detect chikungunya virus infection in Yangon, Myanmar(Soe Thein et al, 1992), our
recent study serves as an additional indicator for its application in Myanmar.
Table 2. Dengue positive case detection by IgM-ELISA using different
serotypic antigens raised by cell culture methods
Assay ELISA Positive # to total % total
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